Anti-Xa Level With Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19 and Non-COVID-19 Patients

Clinical trial NCT05926518 · COMPLETED

Trial details

NCT number: NCT05926518
Sponsor: Rijnstate Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Critical Illness Therapeutic Drug Monitoring Venous Thromboembolism

Start date: 2020-11-01
Primary completion: 2022-04-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.